You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《半日速報》恆指半日收報24,244點 跌121點; 恆生科技指數半日收報5,393點 跌57點 中生製藥升逾15% 建行、中生製藥、紫金礦業、藥明康德、翰森製藥創新高
恆指半日收24,244點,跌121點或0.5%。恆生科技指數報5,393點,跌57點或1.1%。國指跌45點或0.5%,報8,820點。 活躍重磅股表現: 阿里巴巴(09988.HK) 收116元,下跌2%; 港交所(00388.HK) 收417元,下跌0.8%; 建行(00939.HK) 收7.71元,上升0.8%,創新高; 平安(02318.HK) 收49.05元,上升0.6%; 騰訊(00700.HK) 收515元,下跌0.6%; 美團(03690.HK) 收144.2元,上升0.3%; 異動恆指及國指成份股: 中生製藥(01177.HK) 收5.49元,上升15.1%,創新高; 紫金礦業(02899.HK) 收20.15元,上升5.7%,創新高; 百濟神州(06160.HK) 收167.5元,上升5.4%; 小鵬汽車(09868.HK) 收77.75元,下跌5%; 快手-W(01024.HK) 收59.25元,下跌4.7%; 百威亞太(01876.HK) 收8.23元,下跌4.4%; 藥明康德(02359.HK) 收77.95元,上升4%,創新高; 翰森製藥(03692.HK) 收29.9元,上升3.8%,創新高; 藥明生物(02269.HK) 收27.6元,上升3.6%; 阿里健康(00241.HK) 收4.75元,上升3.3%; 異動綜合中小型股: 美中嘉和(02453.HK) 收7.39元,上升13%; 健康之路(02587.HK) 收50.25元,下跌12.7%; ~
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account